// App-Quantinova.ai

Sa1213 : Safety of Adalimumab in Global Clinical Trials of Ulcerative Colitis Patients

Researchers

Presenter

  • Subrata Ghosh

Principal Investigators

  • William Sandborn

  • Gert A. Van Assche

  • Walter Reinisch

  • Andreas Lazar

  • Samantha Eichner

  • Bidan Huang

  • Anne Robinson

  • Roopal Thakkar

Medical Centers

  • University of California, San Diego, La Jolla, CA

  • Medical University of Vienna, Vienna, Austria

  • University of Toronto, Toronto, ON, Canada

  • University of Leuven, KUL, Leuven, Belgium

  • University of Calgary, Calgary, AB, Canada

  • Centre Hospitalier Universitaire Marseille, Marseille, France

Locations

  • Canada

  • Austria

  • United States

  • France

  • Belgium

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Cluster of Differentiation 2AP

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • open label

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved